Conjunctivitis Research Today is a free monthly online journal that collates and summarizes the latest research about Conjunctivitis, including details on pink eye, symptoms, causes, treatment, medication.

Volume 6 (2009), Issue 8 (August)

1. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
   J Ocul Pharmacol Ther, 25(4): 321-8. [Abstract] [Full-text]
2. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
   J Ocul Pharmacol Ther, 25(4): 365-72. [Abstract] [Full-text]
3. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
   Acta Ophthalmol, 87(5): 549-54. [Abstract] [Full-text]
4. Nucleotide sequence variation in the hexon gene of human adenovirus type 8 and 37 strains from epidemic keratoconjunctivitis patients in Japan.
   J Gen Virol, 90: 2260-5. [Abstract] [Full-text]
5. Trachoma, cataracts and uncorrected refractive error are still important contributors to visual morbidity in two remote indigenous communities of the Northern Territory, Australia.
   Clin Experiment Ophthalmol, 37(6): 550-7. [Abstract] [Full-text]
6. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye.
   Clin Experiment Ophthalmol, 37(6): 541-9. [Abstract] [Full-text]
7. Spontaneous T cell mediated keratoconjunctivitis in Aire-deficient mice.
   Br J Ophthalmol, 93(9): 1260-4. [Abstract] [Full-text]
8. Allergic conjunctivitis and latent infections.
   Cornea, 28(8): 839-42. [Abstract] [Full-text]
9. Emerging drugs for conjunctivitis.
   Expert Opin Emerg Drugs, 14(3): 523-36. [Abstract] [Full-text]

© 2004-2010 Conjunctivitis Research Today. All Rights Reserved.